期刊文献+

产气荚膜梭菌β2蛋白的高效可溶性表达与基因工程亚单位疫苗的制备 被引量:3

The efficient and soluble expression of β2 protein of Clostridium perfringens and the preparation of genetic engineering subunit vaccine
原文传递
导出
摘要 β2毒素是一种新近报道的产气荚膜梭菌(Clostridium perfringens)毒素,A、B、C、D、E等5个型的梭菌均可产生,该毒素也是制备基因工程亚单位疫苗的主要研究对象。本研究通过优化β2蛋白的密码子、去除蛋白信号肽,选择亲水性与抗原性较好的序列,同时优化表达条件等方法的探索,在大肠杆菌表达系统中获得了高效表达的可溶性重组β2蛋白,用该蛋白免疫小鼠可使动物产生较高的血清抗体水平,针对A型、B型、C型和D型产气荚膜梭菌的保护率分别为90%、100%、80%和90%,小鼠三免后第7~14天抗体效价达到峰值。本研究表达的β2蛋白具有较好的免疫原性,可进一步用于研制预防产气荚膜梭菌的基因工程亚单位疫苗。 β2 toxin is the most important toxin in all types of Clostridium perfringens(A,B,C,D and E),and it is the main research object in preparing of genetic engineering subunit vaccine.According to optimization of codon,removal of the signal peptide,select better hydrophilicity and antigenic sequences,and optimize the expression conditions in this study,we obtained the soluble β2 fusion protein in Escherichia coli expression system.In addition,on the basis of β2 protein,we developed genetic engineering subunit vaccine for the inhibition of mixed infection of several types Clostridium perfringens.The serum antibody level increased obviously after immuning,and it could resist the attack of Clostridium perfringens.The vaccine could resist the attack of type A,B,C and D of Clostridium perfringens,and immune protection rate of the mouse were up to 90%,100%,80% and 90%,respectively.From day 7 to 14 after the third immune,the antibody titer in mice reached a peak. The vaccine can be used to control the disease caused by Clostridium perfringens infection,and it has a good application prospect.
出处 《中国兽医科学》 CAS CSCD 北大核心 2016年第12期1531-1537,共7页 Chinese Veterinary Science
基金 国家重点计划研发项目(2016YFD0500901)
关键词 产气荚膜梭菌 β2蛋白 可溶性表达与纯化 基因工程亚单位疫苗 Clostridium perfringens β2 protein soluble expression and purification genetic engineering subunit vaccine
  • 相关文献

参考文献3

二级参考文献48

  • 1邓志爱,李孝权,李钏华,张健,张欣强,庞杏林,张颖,莫自耀.食品中产气荚膜梭菌的分离鉴定与基因分型[J].热带医学杂志,2006,6(6):682-684. 被引量:25
  • 2陆承平.兽医微生物学[M].4版.北京:中国农业出版社.2007:101-106.
  • 3[1]Awad MM,Ellemor DM,Bryant AE,Matsushita O,Boyd RL,Stevens DL,Emmins JJ,Rood JI.Construction and virulence testing of a collagenase mutant of Clostridium perfringens.Microb Pathog 2000; 28:107-117
  • 4[2]Ochi S,Oda M,Matsuda H,Ikari S,Sakurai J.Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes.J Biol Chem 2004; 279:12181-12189
  • 5[3]Sheedy SA,Ingham AB,Rood JI,Moore RJ.Highly conserved alpha-toxin sequences of avian isolates of Clostridium perfringens.J Clin Microbiol 2004; 42:1345-1347
  • 6[4]O'Brien DK,Melville SB.Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages,on escape from the phagosomes of macrophages,and on persistence of C.perfringens in host tissues.Infect Immun 2004; 72:5204-5215
  • 7[5]Flores-Diaz M,Alape-Giron A.Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene.Toxicon 2003; 42:979-986
  • 8[6]Sambrook J,Fristch EF,Maniatis T.Molecular Cloning.2nd Ed.Cold Spring Harbor.New York:Cold Spring Harbor Laboratory Press.1989
  • 9[7]Rood JI,Cole ST.Molecular genetics and pathogenesis of Clostridium perfringens.Microbiol Rev 1991; 55:621-648
  • 10[8]Bennett AM,Lescott T,Phillpotts RJ,Mackett M,Titball RW.Recombinant vaccinia viruses protect against Clostridium perfringens alpha-toxin.Viral Immunol 1999; 12:97-105

共引文献11

同被引文献19

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部